| 摘要 |
Provided are methods and compositions for increasing CD4+ cell count in mammals, preferably by at least 25%, while undergoing treatment for various conditions whose treatment can have detrimental effects on immune system function. Such conditions include, but are not limited to, HIV infection, cancer, and hepatitis. The compositions include alpha lipoic acid; acetyl L-carnitine; N-acetyl-cysteine; and optionally: zinc, selenium, vitamin C, bioflavinoid complex, vitamin E, co-enzyme Q10, glutathione, beta-carotene, vitamin A, vitamin B1, vitamin B2, vitamin B6, niacinamide, calcium pantothenate, folic acid, vitamin B12, copper, manganese, chromium, and molybdenum. |
| 主权项 |
1. A method of increasing a mammal's CD4+ cell count while undergoing therapy for treatment of a condition selected from the group consisting of immune-mediated diseases, cancer, heart disease, neurodegenerative disease, and infectious disease, comprising:
administering to the mammal, during a treatment period, a nutrient composition and at least one drug effective for treatment of said condition; the nutrient composition comprising, in per kg body weight per day:
1.43 mg to 11.42 mg alpha lipoic acid;3.57 mg to 28.58 mg acetyl L-carnitine; and4.28 mg to 34.28 mg N-acetyl-cysteine; whereby the mammal's CD4+ cell count is increased during the treatment period. |
